U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378865) titled 'Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants' on Jan. 23.
Brief Summary: The purpose of the study is to evaluate the pharmacokinetics (PK) of suzetrigine (SUZ) and its active metabolite in breast milk of lactating female participants. In addition, the purpose is also to evaluate the relative infant dose (RID), safety and tolerability of SUZ and its active metabolite in lactating female participants.
Study Start Date: Feb. 03
Study Type: INTERVENTIONAL
Condition:
Pain
Intervention:
DRUG: Suzetrigine
Tablets for Oral Administration.
Recruitment Status: NOT_YET_RECRUITING...